tiprankstipranks
Barinthus Biotherapeutics (DE:2AB)
FRANKFURT:2AB
Germany Market

Barinthus Biotherapeutics (2AB) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Barinthus Biotherapeutics’s (2AB) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Barinthus Biotherapeutics is a Buy.
Barinthus Biotherapeutics’s (2AB) 20-Day exponential moving average is 0.54, while Barinthus Biotherapeutics’s (2AB) share price is €1.09, making it a Sell.
Barinthus Biotherapeutics’s (2AB) 50-Day exponential moving average is 0.54, while Barinthus Biotherapeutics’s (2AB) share price is €1.09, making it a Sell.

Barinthus Biotherapeutics (2AB) Pivot Points

Jul 15, 2026, 07:25 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.53
0.53
0.53
0.53
0.53
0.53
0.53
Fibonacci
0.53
0.53
0.53
0.53
0.53
0.53
0.53
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Barinthus Biotherapeutics (2AB) Moving Averages

Jul 15, 2026, 07:25 AM
Period
Simple
Exponential
MA5
0.52Buy
0.53Sell
MA10
0.53Sell
0.53Sell
MA20
0.55Sell
0.54Sell
MA50
0.55Sell
0.54Sell
MA100
0.52Buy
0.56Sell
MA200
0.64Sell
0.68Sell
Barinthus Biotherapeutics’s (2AB) 10-Day exponential moving average is 0.53, while Barinthus Biotherapeutics’s (2AB) share price is €1.09, making it a Sell.
Barinthus Biotherapeutics’s (2AB) 100-Day exponential moving average is 0.56, while Barinthus Biotherapeutics’s (2AB) share price is €1.09, making it a Sell.
Barinthus Biotherapeutics’s (2AB) stock price is €1.09 and Barinthus Biotherapeutics’s (2AB) 50-day simple moving average is 0.55, creating a Sell signal.
Barinthus Biotherapeutics’s (2AB) stock price is €1.09 and Barinthus Biotherapeutics’s (2AB) 100-day simple moving average is 0.52, creating a Buy signal.
Barinthus Biotherapeutics’s (2AB) stock price is €1.09 and Barinthus Biotherapeutics’s (2AB) 200-day simple moving average is 0.64, creating a Sell signal.

Barinthus Biotherapeutics (2AB) Technical Indicators

Jul 15, 2026, 07:25 AM
Name
Value
Implied Action
RSI (14)
45.01
Neutral
STOCH (9,6)
19.94
Buy
STOCHRSI (14)
12.50
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
9.48
Buy
Williams %R
-87.50
Buy
CCI (14)
-83.55
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
36.37
Neutral
ROC
-4.55
Sell
Barinthus Biotherapeutics’s (2AB) Relative Strength Index (RSI) is 45.01, creating a Neutral signal.
Barinthus Biotherapeutics’s (2AB) Trend Strength Indicator (ADX) is 9.48, creating a Buy signal.
Barinthus Biotherapeutics’s (2AB) Commodity Channel Index (CCI) is -83.55, creating a Neutral signal.
Barinthus Biotherapeutics’s (2AB) Price Rate of Change (ROC) is -4.55, creating a Sell signal.

FAQ

Is 2AB a Buy, Hold, or Sell?
Based on 2AB’s technical indicators, 2AB is a Sell.
    What is 2AB’s RSI (14)?
    2AB’s RSI (14) is 45.01, which suggests 2AB is a Neutral.
      What is 2AB’s MACD?
      2AB’s MACD is >-0.01, which suggests 2AB is a Buy.
        What is 2AB’s 5-day moving average?
        2AB’s 5-day moving average is 0.52, which suggests 2AB is a Buy.
          What is 2AB’s 20-day moving average?
          2AB 20-day moving average is 0.55, which suggests 2AB is a Sell.
            What is 2AB’s 50-day moving average?
            2AB’s 50-day moving average is 0.55, which suggests 2AB is a Sell.
              What is 2AB’s 200-day moving average?
              2AB’s 200-day moving average is 0.64, which suggests 2AB is a Sell.
                What is 2AB’s Williams % R (14)?
                2AB’s Williams % R (14) is -87.50, which suggests 2AB is a Buy.
                  What is 2AB’s CCI (14)?
                  2AB’s CCI (14) is -83.55, which suggests 2AB is a Neutral.
                    What is the share price of Barinthus Biotherapeutics?